Allergy Immunotherapy Market - Trends Forecast Till 2028

Allergy Immunotherapy Market Size, Share & Trends Analysis Report, By Treatment Type (SCIT, SLIT), By Allergy Type (Allergic Rhinitis, Asthma), By Distribution Channel, and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: November, 2021

Base Year Estimate: 2020

Report ID: D-PH-AIM-440


Number of Pages: 440

Domain: Pharmaceutical

Allergy Immunotherapy Market – Trends Forecast Till 2028

The global allergy immunotherapy market size was valued at USD 1.6 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 9.0% during the forecast period 2021-2028.

Allergy immunotherapy is used for the treatment of allergic asthma, allergic rhinitis/conjunctivitis, and stringent insect hypersensitivity.

The rising prevalence of allergic disorders and their burden across the globe and Complex allergies with higher morbidity serve as a burden on the healthcare system are some of the factors that have supported long-term expansion for Allergy Immunotherapy Market.

The COVID-19 pandemic is causing widespread concern and economic hardship for consumers, businesses, and communities across the globe. It is expected that the allergy immunotherapy market in the global market will recover from this global pandemic situation by the end of the second quarter and the beginning of the third quarter in the coming year during the forecasted period from 2017 to 2023.

Allergy Immunotherapy Market Report

Europe accounted for the largest share of 69.1% in 2019 and is expected to hold its position throughout the forecast period. However, Asia Pacific is projected to register the fastest CAGR throughout the forecast period.

Allergy Immunotherapy Market is segmented into treatment type, allergy type, distribution channel and region.

On the basis of Treatment Type

  • Subcutaneous Immunotherapy (SCIT)
  • Sublingual Immunotherapy (SLIT)

On the basis of Allergy Type

  • Allergic rhinitis
  • Allergic asthma

On the basis of Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

On the basis of Region

  • Asia Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa

Insights are provided for each region and major countries within the regions

Allergy Immunotherapy Market Primary Respondent


Key Players

  • ASIT Biotech
  • Circassia
  • Mylan N.V.
  • Adamis Pharmaceuticals Corporation
  • Merck KGaA, Stallergenes Greer plc
  • Allergy Therapeutics
  • ALK-Abelló A/S
  • HAL Allergy B.V.
  • HollisterStier Allergy
  • LETIPharma
  • DBV Technologies SA.

Recent Developments

  • ALK Abello A/S took off the working assets allergy laboratory in Oklahoma Incand crystal labs in January 2017.
  •  Stallergenes S.A and DVB Technologies entered into a research agreement with Stallergenes S.A. for the birch allergy treatment in October 2017.

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
  • Gain authentic and granular data access for Allergy Immunotherapy Market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope


Report Feature


Growth Rate

CAGR of 9.0% during the forecasting period, 2021-2027

Historical Data


Forecast Years


Base Year


Units Considered

Revenue in USD billion and CAGR from 2021 to 2027

Report Segmentation

material type, end use, implementation and geography

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

ASIT Biotech, Circassia, Mylan N.V., Adamis Pharmaceuticals Corporation, Merck KGaA, Stallergenes Greer plc, Allergy Therapeutics, ALK-Abelló A/S, DESENTUM OY, HAL Allergy B.V., HollisterStier Allergy, LETIPharma, and DBV Technologies SA.

Available Customization

In addition to the market data for Allergy Immunotherapy Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.

Regional Report

Note: Report data and information will be by Country.

Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.